About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)
About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
Logout
Obstetrics and Gynegology2025№10

Preservation of reproductive health as a basis for increasing birth rates. A joint position of experts in reproductive medicine, obstetrics and gynecology, endocrinology, and clinical pharmacology

DOI
https://dx.doi.org/10.18565/aig.2025.265

Sukikh G.T., Serov V.N., Podzolkova N.M., Baranov I.I., Andreeva M.D., Artymuk N.V., Bezhenar V.F., Dolgushina N.V., Dubrovina S.O., Enkova E.V., Gabidullina R.I., Katkova N.Yu., Kogan I.Yu., Korennaya V.V., Kukarskaya I.I., Makarenko T.A., Molchanova I.V., Nazarenko T.A., Olenev A.S., Savelieva I.V., Semenov Yu.A., Smetnik A.A., Spiridonova N.V., Tapilskaya N.I., Tetruashvili N.K., Uvarova E.V., Fadeev V.V., Shikh E.V., Yarmolinskaya M.I.

For citation: Sukikh G.T., Serov V.N., Podzolkova N.M., Baranov I.I., Andreeva M.D., Artymuk N.V., Bezhenar V.F., 
Dolgushina N.V., Dubrovina S.O., Enkova E.V., Gabidullina R.I., Katkova N.Yu., Kogan I.Yu., Korennaya V.V., Kukarskaya I.I., Makarenko T.A., Molchanova I.V., Nazarenko T.A., Olenev A.S., Savelieva I.V., Semenov Yu.A., 
Smetnik A.A., Spiridonova N.V., Tapilskaya N.I., Tetruashvili N.K., Uvarova E.V., Fadeev V.V., Shikh E.V., 
Yarmolinskaya M.I. Preservation of reproductive health as a basis for increasing birth rates. A joint position of 
experts in reproductive medicine, obstetrics and gynecology, endocrinology, and clinical pharmacology. 
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2025; (10): 180-192 (in Russian)
https://dx.doi.org/10.18565/aig.2025.265

Full text (in Russian)

References

  1. Peeples L. People are having fewer babies: Is it really the end of the world? Nature. 2025; 644(8077): 594-6.
  2. Федеральная служба государственной статистики (Росстат). Коэффициенты рождаемости, смертности и естественного прироста населения. 2025. Доступно по: https://rosstat.gov.ru/bgd/regl/b13_13/IssWWW.exe/Stg/d4/26-05.htm [Federal State Statistics Service (Rosstat). Birth, death, and natural population growth rates. 2025. Available at: https://rosstat.gov.ru/bgd/regl/b13_13/IssWWW.exe/Stg/d4/26-05.htm (in Russian)].
  3. Fauser B.C.J.M., Adamson G.D., Boivin J., Chambers G.M., de Geyter C., Dyer S. et al.; Contributors and members of the IFFS Demographics and Access to Care Review Board. Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature. Hum. Reprod. Update. 2024; 30(2): 153-73. https://dx.doi.org/10.1093/humupd/dmad028
  4. Министерство здравоохранения Российской Федерации. Национальные проекты России: «Продолжительная и активная жизнь», «Новые технологии сбережения здоровья», «Семья». 2025. Доступно по: https://minzdrav.gov.ru/poleznye-resursy/natsionalnye-proekty-rossii-prodolzhitelnaya-i-aktivnaya-zhizn-novye-tehnologii-sberezheniya-zdorovya [Ministry of Health of the Russian Federation. National Projects of Russia: "Long and Active Life", "New Technologies for Health Conservation", "Family". 2025. Available at: https://minzdrav.gov.ru/poleznye-resursy/natsionalnye-proekty-rossii-prodolzhitelnaya-i-aktivnaya-zhizn-novye-tehnologii-sberezheniya-zdorovya (in Russian)].
  5. Министерство здравоохранения Российской Федерации. Итоговая коллегия 2024 и планы на 2025: Ключевая задача системы здравоохранения — сохранить жизни и здоровье граждан. 2025. Доступно по: https://minzdrav.gov.ru/news/2025/05/16/25211-itogovaya-kollegiya-2024-i-plany-na-2025-klyuchevaya-zadacha-sistemy-zdravoohraneniya-sohranit-zhizni-i-zdorovie-grazhdan [Ministry of Health of the Russian Federation. The final board of 2024 and plans for 2025: The key objective of the healthcare system is to preserve the lives and health of citizens. 2025. Available at: https://minzdrav.gov.ru/news/2025/05/16/25211-itogovaya-kollegiya-2024-i-plany-na-2025-klyuchevaya-zadacha-sistemy-zdravoohraneniya-sohranit-zhizni-i-zdorovie-grazhdan (in Russian)].
  6. Министерство здравоохранения Российской Федерации. Федеральный проект «Здоровье для каждого». 2025. Доступно по: https://minzdrav.gov.ru/poleznye-resursy/natsionalnye-proekty-rossii-prodolzhitelnaya-i-aktivnaya-zhizn-novye-tehnologii-sberezheniya-zdorovya/struktura-i-klyuchevye-meropriyatiya-federalnogo-proekta-zdorovie-dlya-kazhdogo [Ministry of Health of the Russian Federation. Federal project "Health for Everyone". 2025. Available at: https://minzdrav.gov.ru/poleznye-resursy/natsionalnye-proekty-rossii-prodolzhitelnaya-i-aktivnaya-zhizn-novye-tehnologii-sberezheniya-zdorovya/struktura-i-klyuchevye-meropriyatiya-federalnogo-proekta-zdorovie-dlya-kazhdogo (in Russian)].
  7. Воробьева О.Д. Тренды и перспективы демографического старения и миграции населения в мире и России. Российский научный фонд, проект №22-28-01549. 2023. Доступно по: https://rscf.ru/project/22-28-01549/ [Vorobyeva O.D. Trends and prospects of demographic aging and population migration in the world and Russia. Russian Science Foundation, project No. 22-28-01549. 2023. Available at: https://rscf.ru/project/22-28-01549/ (in Russian)].
  8. Трофимов Д.Ю. Разработка генетически обоснованных подходов к реализации репродуктивного потенциала пациентов и их семей при нарушениях формирования и функционирования репродуктивной системы. ФГБУ «НМИЦ АГП им. В.И. Кулакова» Минздрава России; 2025. Доступно по: https://rscf.ru/upload/iblock/9f7/rx5hjj7hrdv2dfejdjrt0bxoozvw542b.pdf [Trofimov D.Yu. Development of genetically based approaches to the implementation of the reproductive potential of patients and their families in case of disorders of the formation and functioning of the reproductive system. FGBU "V.I. Kulakov NMRC for OGP" of the Ministry of Health of the Russian Federation; 2025. Available at: https://rscf.ru/upload/iblock/9f7/rx5hjj7hrdv2dfejdjrt0bxoozvw542b.pdf (in Russian)].
  9. Лунёва И.С., Иванова О.Ю., Хардиков А.В., Абросимова Н.В. Факторы, влияющие на рождаемость в современной России. Российский вестник акушера-гинеколога. 2019; 19(2): 14-20. [Lunyova I.S., Ivanova O.Iu., Khardikov A.V., Abrosimova N.V. Factors influencing the birth rates in modern Russia. Russian Bulletin of Obstetrician-Gynecologist. 2019; 19(2): 14-20. (in Russian)]. https://dx.doi.org/10.17116/rosakush2019190211410.
  10. Российское общество акушеров-гинекологов (РОАГ). Миссия, цели и задачи. Доступно по: https://roag-portal.ru/mission?ysclid=mfz7lm7n8f563366638 [Russian Society of Obstetrician and Gynecologists. Mission, goals and objectives. Available at: https://roag-portal.ru/mission?ysclid=mfz7lm7n8f563366638 (in Russian)].
  11. Министерство здравоохранения Российской Федерации. Итоги реализации национального проекта «Здравоохранение». 2025. Доступно по: https://minzdrav.gov.ru/ministry/natsproektzdravoohranenie/itogi-realizatsii-natsionalnogo-proekta-zdravoohranenie [Ministry of Health of the Russian Federation. Results of the National Project "Healthcare". 2025. Available at: https://minzdrav.gov.ru/ministry/natsproektzdravoohranenie/itogi-realizatsii-natsionalnogo-proekta-zdravoohranenie (in Russian)].
  12. Volsche S. Voluntarily childfree: Identity and kinship in the United States. Lanham, MD: Lexington Books; 2019.
  13. Конституция Российской Федерации (1993/2020). Конституция Российской Федерации с изменениями, одобренными в ходе общероссийского голосования 1 июля 2020 года. Доступно по: https://pravo.gov.ru/constitution/ [Constitution of the Russian Federation (1993/2020). Constitution of the Russian Federation with amendments approved during the all-Russian vote on July 1, 2020. Available at: https://pravo.gov.ru/constitution/ (in Russian)].
  14. Федеральный закон от 21 ноября 2011 г. № 323-ФЗ «Об основах охраны здоровья граждан в Российской Федерации» (ред. от 28.12.2024). Доступно по: https://normativ.kontur.ru/document?moduleId=1&documentId=490072 [Federal Law No. 323-FZ dated November 21, 2011 “On the Fundamentals of Protecting the Health of Citizens in the Russian Federation” (as amended on December 28, 2024). Available at: https://normativ.kontur.ru/document?moduleId=1&documentId=490072 (in Russian)].
  15. Всероссийский центр изучения общественного мнения (ВЦИОМ). Репродуктивные планы россиян: два пишем, три в уме? 2025. Доступно по: https://wciom.ru/analytical-reviews/analiticheskii-obzor/reproduktivnye-plany-rossijan-dva-pishem-tri-v-ume [All-Russian Public Opinion Research Center (VTsIOM). Reproductive Plans of Russians: Two in Writing, Three in Mind? 2025. Available at: https://wciom.ru/analytical-reviews/analiticheskii-obzor/reproduktivnye-plany-rossijan-dva-pishem-tri-v-ume (in Russian)].
  16. Federal Statistical Office of Germany (Destatis). Decline in fertility rate slowed significantly in 2024. 2025, July 17. Available at: https://www.destatis.de/EN/Themes/Society-Environment/Population/Births/_node.html
  17. Ministry of Health, Labour and Welfare of Japan. Vital statistics of Japan: Total fertility rate in 2024. Available at: https://www.nippon.com/en/japan-data/h02429/
  18. Письмо Минздрава России от 16.10.2024 N 15-4/И/2-20549 «О направлении Методических рекомендаций "Сохранение и укрепление репродуктивного здоровья работающих граждан"» (вместе с «Методическими рекомендациями "Сохранение и укрепление репродуктивного здоровья работающих граждан"», утв. ФГБУ "НМИЦ ТПМ" Минздрава России 17.09.2024). Доступно по: https://legalacts.ru/doc/pismo-minzdrava-rossii-ot-16102024-n-15-4i2-20549-o-napravlenii/ [Letter of the Ministry of Health of Russia dated 16.10.2024 N 15-4/I/2-20549 On the direction of the Methodological Recommendations "Preservation and Strengthening of the Reproductive Health of Working Citizens" (together with the Methodological Recommendations "Preservation and Strengthening of the Reproductive Health of Working Citizens", approved by FSBI "NMRC TPM" of the Ministry of Health of Russia 17.09.2024). Available at: https://legalacts.ru/doc/pismo-minzdrava-rossii-ot-16102024-n-15-4i2-20549-o-napravlenii/ (in Russian)].
  19. Du Pasquier-Fediaevsky L., Tubiana-Rufi N. Discordance between physician and adolescent assessments of adherence to treatment: influence of HbA1c level. The PEDIAB Collaborative Group. Diabetes Care. 1999; 22(9):1445-9. https://dx.doi.org/10.2337/diacare.22.9.1445.
  20. Rand C.S., Wise R.A., Nides M., Simmons M.S., Bleecker E.R., Kusek J.W. et al. Metered-dose inhaler adherence in a clinical trial. Am. Rev. Respir. Dis. 1992; 146(6): 1559-64. https://dx.doi.org/10.1164/ajrccm/146.6.1559
  21. International Federation of Gynecology and Obstetrics (FIGO). Ethical framework for respectful maternity care during pregnancy and childbirth. 2021. Available at: https://www.figo.org/sites/default/files/2021-09/FIGO_Statement_Ethical-Framework-Respectful-Maternity-Care-During-Pregnancy-Childbirth_0.pdf
  22. Rubak S., Sandbaek A., Lauritzen T., Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br. J. Gen. Pract. 2005; 55(513): 305-12.
  23. Ryan R.M., Deci E.L. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. American Psychologist. 2000 ; 55(1) : 68-78. https://dx.doi.org/10.1037110003-066X.55.1.68
  24. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Дисменорея. 2021. [Ministry of Health of the Russian Federation. Clinical guidelines. Dysmenorrhea. 2021. (in Russian)].
  25. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Эндометриоз. 2024. [Ministry of Health of the Russian Federation. Clinical guidelines. Endometriosis. 2024. (in Russian)].
  26. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Синдром поликистозных яичников. 2024. [Ministry of Health of the Russian Federation. Clinical guidelines. Polycystic ovary syndrome. 2024. (in Russian)].
  27. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Преждевременная недостаточность яичников. 2024. [Ministry of Health of the Russian Federation. Clinical guidelines. Premature ovarian failure. 2024. (in Russian].
  28. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Аномальные маточные кровотечения. 2024.  [Ministry of Health of the Russian Federation. Clinical guidelines. Abnormal uterine bleeding. 2024. (in Russian)].
  29. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Аменорея и олигоменорея. 2021. [Ministry of Health of the Russian Federation. Clinical guidelines. Amenorrhea and oligomenorrhea. 2021. (in Russian)].
  30. Министерство культуры Российской Федерации. Национальный проект «Семья». По состоянию на 4 сентября 2025 года. Доступно по: https://culture.gov.ru/about/national-project/natsionalnyy-proekt-semya/ [Ministry of Culture of the Russian Federation. Family National Project. As of September 4, 2025. Available at: https://culture.gov.ru/about/national-project/natsionalnyy-proekt-semya/ (in Russian)].
  31. Письмо Министерства здравоохранения Российской Федерации от 8 апреля 2024 г. № 17-6/И/2-6434 «О направлении методических рекомендаций по диспансеризации мужчин и женщин репродуктивного возраста с целью оценки репродуктивного здоровья». Доступно по: https://www.garant.ru/products/ipo/prime/doc/408788357/ [Letter of the Ministry of Health of the Russian Federation of April 8, 2024 No. 17-6/I/2-6434 "On the direction of methodological recommendations for the medical examination of men and women of reproductive age in order to assess reproductive health". Available at: https://www.garant.ru/products/ipo/prime/doc/408788357/ (in Russian)]
  32. Киселева А. У 32% прошедших репродуктивный скрининг нашли заболевания или риски их развития. Ведомости. 28 декабря 2024. Доступно по: https://www.vedomosti.ru/society/articles/2024/12/28/1084269-reproduktivnii-skrining-nashli [Kiseleva A. 32% of those who underwent reproductive screening found diseases or risks of their development. Vedomosti. December 28, 2024. Available at: https://www.vedomosti.ru/society/articles/2024/12/28/1084269-reproduktivnii-skrining-nashli (in Russian)].
  33. Liu J.H. Endometriosis. MSD Manual. Professional version. Available at: https://www.msdmanuals.com/professional/gynecology-and-obstetrics/endometriosis/endometriosis
  34. Всемирная организация здравоохранения. Каждый шестой человек в мире страдает от бесплодия. 4 апреля 2023 г. Доступно по: https://www.who.int/ru/news/item/04-04-2023-1-in-6-people-globally-affected-by-infertility [World Health Organization. One in six people in the world suffers from infertility. April 4, 2023. Available at: https://www.who.int/ru/news/item/04-04-2023-1-in-6-people-globally-affected-by-infertility (in Russian)].
  35. Проект Приказа Минздрава России «Об утверждении порядка применения клинических рекомендаций». 30.07.2025. Доступно по: https://www.consultant.ru/law/hotdocs/90226.html [Draft Order of the Ministry of Health of Russia "On Approval of the Procedure for the Application of Clinical Guidelines". 30.07.2025. Available at: https://www.consultant.ru/law/hotdocs/90226.html (in Russian)].
  36. Карайланов М.Г., Ужох-Бажноков О.А., Моисеева К.Е., Алексеева А.В., Дайнеко М.Ю., Горланов И.А. Основные направления улучшения диспансерного наблюдения за пациентами с применением цифровых технологий. Медицина и организация здравоохранения. 2024; 9(1): 136-50. [Karailanov M.G., Uzhokh-Bazhnokov O.A., Moiseeva K.E., Alekseeva A.V., Daineko M.Yu., Gorlanov I.A. The main directions of improving dispensary monitoring of patients using digital technologies. Medicine and Health Care Organization. 2024; 9(1): 136-50 (in Russian)]. https://dx.doi.org/10.56871/MHC0.2024.40.98.011
  37. Минздрав подготовил анкету для решившихся на аборт. Ведомости. 03 мая 2023. Доступно по: https://www.vedomosti.ru/society/news/2023/05/03/973573-minzdrav-podgotovil-anketu-dlya-reshivshihsya-na-abort [The Ministry of Health has prepared a questionnaire for those who decide on an abortion. Vedomosti. May 03, 2023. Available at: https://www.vedomosti.ru/society/news/2023/05/03/973573-minzdrav-podgotovil-anketu-dlya-reshivshihsya-na-abort (in Russian)].
  38. СПб ГБУЗ «Городской центр охраны репродуктивного здоровья подростков «Ювента»». Анкетирование с целью снижения числа случаев прерывания беременности. 2023. Доступно по: https://juventa-spb.info/poleznaya-informatsiya/i_anketirovanie-s-tselyu-snizheniya-chisla-sluchaev-prerivaniya-beremennosti/ [St. Petersburg State Budgetary Healthcare Institution "City Center for Adolescent Reproductive Health "Yuventa". Questionnaire to reduce the number of terminations. 2023. Available at: https://juventa-spb.info/poleznaya-informatsiya/i_anketirovanie-s-tselyu-snizheniya-chisla-sluchaev-prerivaniya-beremennosti/ (in Russian)].
  39. Беженарь В.Ф., Нестеров И.М. Реализация проекта охраны репродуктивного здоровья и диспансеризации женщин: опыт Санкт-Петербурга в рамках стратегии цифровой трансформации отрасли. ОРГЗДРАВ: новости, мнения, обучение. Вестник ВШОУЗ. 2024; 10(3): 4-13. [Bezhenar V.F., Nesterov I.M. Implementation of the project for reproductive health protection and medical examination of women: the experience of St. Petersburg within the framework of the strategy for digital transformation of the industry. HEALTHCARE MANAGEMENT: News, Views, Education. Bulletin of VSHOUZ. 2024; 10 (3): 4-13 (in Russian)]. https://dx.doi.org/10.33029/2411-8621-2024-10-3-4-13
  40. Барышникова И.Н., Кетова Г.Г., Зарипова Г.Р., Шамурова Ю.Ю., Кузин А.И., Шамина О.М. Нормативно-правовые аспекты назначения лекарственных препаратов не по инструкции (off-label) в Российской Федерации. Клиническая фармакология и терапия. 2023; 2: 73-9. [Baryshnikovа I.N., Ketova G.G., Zaripova G.R., Shamurova U.U., Ku¬zin A.I., Shamina O.M. Regulatory and legal aspects of the off-label use of medicines in the Russian Federation. Clinical Pharmacology and Therapy. 2023; 32(2): 73-9 (in Russian)]. https://dx.doi.org/10.32756/0869-5490-2023-2-73-79
  41. Zhou Y., Zhang L., Wang H., Li, X. Comorbidities and reproductive health: A cross-sectional analysis of aging populations with cancer and chronic diseases. J. Reprod. Med. 2023; 78(4): 512-26.
  42. GBD 2021 Fertility and Forecasting Collaborators. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024; 403(10440): 2057-99. https://dx.doi.org/10.1016/S0140-6736(24)00550-6
  43. Dai L., Xu D., Li X., Huang S., Duan X., Zheng A. et al. Reproductive health in female patients with systemic sclerosis: a cross-sectional study. Rheumatology. 2024; 63(7): 1911-6. https://dx.doi.org/10.1093/rheumatology/kead497
  44. Karavati E., Karavati D., Kani E.R., Chatziandreou E., Paschou S.A., Psaltopoulou T. et al. The role of anti-Müllerian hormone: insights into ovarian reserve, primary ovarian insufficiency, and menopause prediction. Endocrine. 2025; 89(3): 338-55. https://dx.doi.org/10.1007/s12020-025-04265-0
  45. Namath A., Jahandideh S., Devine K., Kallen C.B., O’Brien J.E. Examining reasons that patients discard cryopreserved oocytes. J. Assist. Reprod. Genet. 2023; 40(10): 2865-70. https://dx.doi.org/10.1007/s10815-023-02962-1
  46. World Health Organization. Menstrual health is a public health and human rights issue. 2022. Available at: https://www.who.int/news/item/24-05-2022-menstrual-health-is-a-public-health-and-human-rights-issue
  47. Munro M.G., Balen A.H., Cho S., Critchley H.O.D., Díaz I., Ferriani R. et al.; FIGO Committee on Menstrual Disorders and Related Health Impacts, and FIGO Committee on Reproductive Medicine, Endocrinology, and Infertility. The FIGO Ovulatory Disorders Classification System. Hum. Reprod. 2022; 37(10): 2446-64. https://dx.doi.org/10.1093/humrep/deac180
  48. Munro M.G., Critchley H.O.D., Fraser I.S.; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int. J. Gynaecol. Obstet. 2018; 143(3): 393-408. https://dx.doi.org/10.1002/ijgo.12666
  49. Лысяк Д.С., Быстрицкая Т.С., Салко И.Н., Стокоз К.Ю. Особенности течения беременности у женщин с нарушениями менструальной функции в пубертатном периоде. Тихоокеанский медицинский журнал. 2019;(2):47-50. [Lysyak D.S., Bystritskaya T.S., Salko I.N., Stokoz K.Yu. Features of the course of pregnancy in women with menstrual dysfunction in puberty. Pacific Medical Journal. 2019; (2): 47-50 (in Russian)]. https://dx.doi.org/10.17238/PmJ1609-1175.2019.2.47-50
  50. Podzolkova N., Tatarchuk T., Doshchanova A., Eshimbetova G., Pexman-Fieth C. Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study. Gynecol. Endocrinol. 2016; 32(3): 246-9. https://dx.doi.org/10.3109/09513590.2015.1115832.
  51. Уварова Е.В., Подзолкова Н.М., Беженарь В.Ф., Енькова Е.В., Ярмолинская М.И., Сметник А.А. Проблемы с циклом или цикл без проблем? Акушерство и гинекология. Мать и Дитя. 2024; 4(42). Доступно по: https://aig-journal.ru/articles/Problemy-s-ciklom-ili-cikl-bez-problem.html [Uvarova E.V., Podzolkova N.M., Bezhenar V.F., Enkova E.V., Yarmolinskaya M.I., Smetnik A.A. Problems with the cycle or a cycle without problems? Obstetrics and Gynecology. Mother and Child. 2024; 4(42). Available at: https://aig-journal.ru/articles/Problemy-s-ciklom-ili-cikl-bez-problem.html (in Russian)].
  52. Донской Д.А., Ужакова М.В. Анализ демографической ситуации в Российской Федерации. Прогноз на 2024–2026 гг. ЭФО. Экономика. Финансы. Общество. 2024; 4(12): 51-61. [Donskoy D.A., Uzhakova M.V. Analysis of the demographic situation in the Russian Federation. Forecast for 2024-2026. EFO. Economics. Finance. Society. 2024; 4(12): 51-61 (in Russian)]. https://dx.doi.org/10.24412/2782-4845-2024-12-51-61
  53. Wasiński P., Dąbrowska N., Kulczyński D., Krzywicka K., Litwin A., Koszyk M. et al. Adverse effects of contraception: A general overview. Medical Science. 2025; 29: e11ms3501. https://dx.doi.org/10.54905/disssi.v29i155.e11ms3501
  54. Dragoman M.V., Tepper N.K., Fu R., Curtis K.M., Chou R., Gaffield M.E. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int. J. Gynaecol. Obstet. 2018; 141(3): 287-94. https://dx.doi.org/10.1002/ijgo.12455
  55. ESOC. Combined oral contraceptives triple risk of cryptogenic stroke in young women, new study shows. 21 May, 2025. Available at: https://medicalxpress.com/news/2025-05-combined-oral-contraceptives-triple-cryptogenic.pdf
  56. Cagnacci A., Biasioli A. The effect of hormonal contraceptives on metabolism. In: Meriggiola M.C., Gemzell-Danielsson K., eds. Female and Male Contraception. Trends in Andrology and Sexual Medicine. Springer, Cham. 2021: 299-317. https://dx.doi.org/10.1007/978-3-030-70932-7_18
  57. Аксенова А.В., Соснова Е.А. Предикторы развития синдрома гиперторможения гонадотропной функции гипофиза после длительного приёма комбинированных оральных контрацептивов. Архив акушерства и гинекологии им. В.Ф. Снегирева. 2018; 5(4): 197-201. [Aksenova A.V., Sosnova E.A. Predictors of the development of syndrome of the hyper-inhibition of gonadotropic function of the hypophysis following long-term intake of combined oral contraceptives. V.F. Snegirev Archives of Obstetrics and Gynecology. Russian journal. 2018; 5(4): 197-201 (in Russian)]. https://dx.doi.org/10.18821/2313-8726-2018-5-4-197-201
  58. Britschgi A.J., Merki G. Combined oral hormonal contraception – an update. GREM. 2024; 5(2): 80-5. https://dx.doi.org/10.53260/grem.245023
  59. Улумбекова Г.Э., Худова И.Ю. Оценка демографического, социального и экономического эффекта применения гормональной терапии при эндометриозе и аномальных маточных кровотечениях. ОРГЗДРАВ: новости, мнения, обучение. Вестник ВШОУЗ. 2022; 8(1): 82-113. [Ulumbekova G.E., Khudova I.Yu. Demographic, social and economic effects of hormonal therapy in endometriosis and abnormal uterine bleeding. HEALTHCARE MANAGEMENT: News, Views, Education. Bulletin of VSHOUZ. 2022; 8(1): 82-113 (in Russian)]. https://dx.doi.org/10.33029/2411-8621-2022-8-1-82-113
  60. Chen Y., Liu C., Wang X., Liu Y., Liu H. Global, regional and national burden of infertility due to endometriosis: results from the global burden of disease study 2021 and forecast to 2044. BJOG. 2025; 132(7): 944-60. https://dx.doi.org/10.1111/1471-0528.18108
  61. Parazzini F., Roncella E., Cipriani S., Trojano G., Barbera V., Herranz B. et al. The frequency of endometriosis in the general and se-lected populations: a systematic review. J. Endometriosis Pelvic Pain Disord. 2020; 12(6): 228402652093314. https://dx.doi.org/10.1177/2284026520933141
  62. Chapron C., Marcellin L., Borghese B., Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat. Rev. Endocrinol. 2019; 15(11): 666-82. https://dx.doi.org/10.1038/s41574-019-0245-z
  63. Allaire C., Bedaiwy M.A., Yong P.J. Diagnosis and management of endometriosis. CMAJ. 2023; 195(10): E363-E371. https://dx.doi.org/10.1503/cmaj.220637
  64. Becker C.M., Bokor A., Heikinheimo O., Horne A., Jansen F., Kiesel L. et al.; ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Hum. Reprod. Open. 2022; 2022(2): hoac009. https://dx.doi.org/10.1093/hropen/hoac009
  65. Pino I., Belloni G.M., Barbera V., Solima E., Radice D., Angioni S. et al.; “Endometriosis Treatment Italian Club” (ETIC”. "Better late than never but never late is better", especially in young women. A multicenter Italian study on diagnostic delay for symptomatic endometriosis. Eur. J. Contracept. Reprod. Health Care. 2023; 28(1): 10-6. https://dx.doi.org/10.1080/13625187.2022.2128644
  66. Vercellini P., Bandini V., Viganò P., Di Stefano G., Merli C.E.M., Somigliana E. Proposal for targeted, neo-evolutionary-oriented, secondary prevention of early-onset endometriosis and adenomyosis. Part I: pathogenic aspects. Hum. Reprod. 2024; 39(1): 1-17. https://dx.doi.org/10.1093/humrep/dead229
  67. Уварова Е.В., Хащенко Е.П., Сальникова И.А., Андреева В.О., Фунда Н.А., Храмова Е.Е., Субботина С.В., Тулендинова А.И., Мардоян М.А.,Городнова Е.А., Сухих Г.Т. Эффективность и безопасность применения дидрогестерона у подростков младше 18 лет с нарушениями менструального цикла. Данные ретроспективного исследования реальной клинической практики. Акушерство и гинекология. 2025; 1: 88-96. [Uvarova E.V., Khashchenko E.P., Salnikova I.A., Andreeva V.O., Funda N.A., Khramova E.E., Subbotina S.B., Tulendinova A.I., Mardoyan M.A., Gorodnova E.A., Sukhikh G.T. Retrospective real world data research program in adolescents under 18 years old with a history of dydrogesterone treatment for menstrual disorders. Obstetrics and Gynecology. 2025; (1): 88-96 (in Russian)]. https://dx.doi.org/10.18565/aig.2025.14
  68. Navarria-Forney I., Bénard J., Mazloum A., Aerts L., Pluchino N., Streuli I. A web-based survey of reproductive awareness and choices in women with endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; 251: 106-13. https://dx.doi.org/10.1016/j.ejogrb.2020.05.012
  69. Cetera G.E., Merli C.E.M., Barbara G., Caia C., Vercellini P. Questionnaires for the assessment of central sensitization in endometriosis: What is the available evidence? A systematic review with a narrative synthesis. Reprod. Sci. 2024; 31(3): 633-44. https://dx.doi.org/10.1007/s43032-023-01343-4
  70. Djokovic D., Pinto P., van Herendael B.J., Laganà A.S., Thomas V., Keckstein J. Structured report for dynamic ultrasonography in patients with suspected or known endometriosis: Recommendations of the International Society for Gynecologic Endoscopy (ISGE). Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 263: 252-60. https://dx.doi.org/10.1016/j.ejogrb.2021.06.035
  71. Сухих Г.Т., Серов В.Н., Адамян Л.В., Баранов И.И., Беженарь В.Ф., Габидуллина Р.И., Дубровина С.О., Козаченко А.В., Подзолкова Н.М., Сметник А.А., Тапильская Н.И., Уварова Е.В., Ших Е.В., Ярмолинская М.И. Алгоритмы ведения пациенток с эндометриозом: согласованная позиция экспертов Российского общества акушеров-гинекологов. Акушерство и гинекология. 2023; 5: 159-76. [Sukhikh G.T., Serov V.N., Adamyan L.V., Baranov I.I., Bezhenar V.F., Gabidullina R.I., Dubrovina S.O., Kozachenko A.V., Podzolkova N.M., Smetnik A.A., Tapilskaya N.I., Uvarova E.V., Shikh E.V., Yarmolinskaya M.I. Algorithms for the management of patients with endometriosis: an agreed position of experts from the Russian Society of Obstetricians and Gynecologists. Obstetrics and Gynecology. 2023; (5): 159-76 (in Russian)]. https://dx.doi.org/10.18565/aig.2023.132
  72. Беженарь В.Ф., Кузьмина Н.С., Круглов С.Ю., Граматикова А.Г., Изоркина В.А., Медведева И.В., Демидов А.Д., Струкова Д.С., Федосова Д.В., Барнаш И.А. Дифференцированные подходы к разработке схем пролонгированной терапии в послеоперационном периоде у пациенток с эндометриозом. Акушерство и гинекология. 2024; 9: 140-8. [Bezhenar V.F., Kuzmina N.S., Kruglov S.Yu., Gramatikova A.G., Izorkina V.A., Medvedeva I.V., Demidov A.D., Strukova D.S., Fedosova D.V., Barnash I.A. Differentiated approaches to the development of prolonged treatment regimens for patients with endometriosis in the postoperative period. Obstetrics and Gynecology. 2024; (9): 140-8 (in Russian)]. https://dx.doi.org/10.18565/aig.2024.203
  73. Christ J.P., Cedars M.I. Current guidelines for diagnosing PCOS. Diagnostics (Basel). 2023; 13(6): 1113. https://dx.doi.org/10.3390/diagnostics13061113
  74. Neven A.C.H., Laven J., Teede H.J., Boyle J.A. A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin. Reprod. Med. 2018; 36(1): 5-12. https://dx.doi.org/10.1055/s-0038-1668085
  75. Sarkar S., Gupta N., Joseph T., Yadav B., Kunjummen A.T., Kamath M.S. Comparison of letrozole versus combination letrozole and clomiphene citrate for ovulation induction in subfertile women with polycystic ovarian syndrome (PCOS)—An open label randomized control trial. Reprod. Sci. 2024; 31(12): 3834-42. https://dx.doi.org/10.1007/s43032-024-01743-0
  76. Freeman A.M., Burks H.R., Wild R.A. Diagnostic criteria and epidemiology of PCOS. In: Pal L., Seifer D.B., eds. Polycystic ovary syndrome. Springer, Cham; 2022: 3-11. https://dx.doi.org/10.1007/978-3-030-92589-5_1
  77. Baradwan S., Al-Shalhoub F., Alshahrani M.S., Himayda S., AlSghan R., Sabban H. et al. Effects of letrozole alone or in combination with gonadotropins on ovulation induction and clinical pregnancy in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized controlled trials. Hormones. 2024; 23: 497-508. https://dx.doi.org/10.1007/s42000-024-00531-4
  78. American Society for Reproductive Medicine (ASRM). Recommendations from the 2023 International Evidence-Based Guideline for the assessment and management of polycystic ovary syndrome. 2023. Available at: https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/
  79. Huang J., Xie Q., Lin J., Lu X., Zhu J., Gao H. et al. Progestin-primed ovarian stimulation with dydrogesterone versus medroxyprogesterone acetate in women with polycystic ovarian syndrome for in vitro fertilization: A retrospective cohort study. Drug Des. Devel. Ther. 2019; 13: 4461-70. https://dx.doi.org/10.2147/DDDT.S230129
  80. Li M., Zhu Y., Wei J., Chen L., Chen S., Lai D. The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis. Climacteric. 2023; 26(2): 95-102. https://dx.doi.org/10.1080/13697137.2022.2153033
  81. Lin S., Chen S., Zhang Q. Factors influencing premature ovarian insufficiency: a systematic review and meta-analysis. J. Obstet. Gynaecol. 2025; 45(1): 2469331. https://dx.doi.org/10.1080/01443615.2025.2469331
  82. European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI; Webber L., Davies M., Anderson R., Bartlett J., Braat D., Cartwright B. et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum. Reprod. 2016; 31(5): 926-37. https://dx.doi.org/10.1093/humrep/dew027
  83. Panay N., Anderson R.A., Bennie A., Cedars M., Davies M., Ee C. et al.; ESHRE, ASRM, CREWHIRL, and IMS Guideline Group on POI. Evidence-based guideline: premature ovarian insufficiency. Hum. Reprod. Open. 2024; 2024(4): hoae065. https://dx.doi.org/10.1093/hropen/hoae065
  84. National Institute for Health and Care Excellence (NICE). Fertility problems: assessment and treatment. Clinical guideline. Available at: https://www.nice.org.uk/guidance/cg156/resources/fertility-problems-assessment-and-treatment-35109634660549
  85. American College of Obstetricians and Gynecologists (ACOG). Infertility: Disparities and access to services (Committee Statement No. 14). January 2025. Available at: https://www.acog.org/clinical/clinical-guidance/committee-statement/articles/2025/01/infertility-disparities-and-access-to-services
  86. European Society of Human Reproduction and Embryology (ESHRE). ESHRE Guideline: Female fertility preservation. 2020. Available at: https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Female-fertility-preservation
  87. Tsui E.L., McDowell H.B., Laronda M.M. Restoring ovarian fertility and hormone function: recent advancements, ongoing efforts and future applications. J. Endocr. Soc. 2024; 8(6): bvae073. https://dx.doi.org/10.1210/jendso/bvae073
  88. Seyhan A., Akin O.D., Ertaş S., Ata B., Yakin K., Urman B. A survey of women who cryopreserved oocytes for non-medical indications (social fertility preservation). Reprod. Sci. 2021; 28(8): 2216-22. https://dx.doi.org/10.1007/s43032-021-00460-2
  89. Şükür Y.E., Aslan B., Kaplan N.B., Doğru M., Özmen B., Sönmezer M. et al. Inter-cycle variability of anti-Müllerian hormone: implications for predicting controlled ovarian stimulation cycle outcomes. J. Ovarian Res. 2024; 17(1): 209. https://dx.doi.org/10.1186/s13048-024-01517-x.
  90. Приказ Министерства здравоохранения Российской Федерации от 14.04.2025 № 203н "Об утверждении критериев оценки качества медицинской помощи". (Зарегистрировано в Минюсте РФ 28.05.2025 № 82382). Доступно по: http://publication.pravo.gov.ru/document/0001202505290045 [Order of the Ministry of Health of the Russian Federation of 14.04.2025 No. 203n "On approval of criteria for assessing the quality of medical care." (Registered in the Ministry of Justice of the Russian Federation 28.05.2025 No. 82382). Available at: http://publication.pravo.gov.ru/document/0001202505290045 (in Russian)].
  91. Письмо Министерства здравоохранения Российской Федерации от 23 мая 2025 г. № 15-4/И2-10255 «О назначении рецептурных лекарственных препаратов». Доступно по: https://www.garant.ru/products/ipo/prime/doc/412164202/ [Letter of the Ministry of Health of the Russian Federation of May 23, 2025 No. 15-4/I2-10255 "On the prescription of prescription drugs". Available at: https://www.garant.ru/products/ipo/prime/doc/412164202/(in Russian)].
  92. Письмо Федеральной службы по надзору в сфере здравоохранения от 7 мая 2025 г. № 01И-426/25 «О соблюдении правил отпуска рецептурных препаратов». Доступно по: https://www.garant.ru/products/ipo/prime/doc/412164206/ [Letter of the Federal Service for Surveillance in Healthcare dated May 7, 2025 No. 01I-426/25"On compliance with the rules for the supply of prescription drugs". Available at: https://www.garant.ru/products/ipo/prime/doc/412164206/ (in Russian)].
  93. Приказ Министерства здравоохранения Российской Федерацииот 24.11.2021 № 1094н "Об утверждении Порядка назначения лекарственных препаратов, форм рецептурных бланков на лекарственные препараты, Порядка оформления указанных бланков, их учета и хранения, форм бланков рецептов, содержащих назначение наркотических средств или психотропных веществ, Порядка их изготовления, распределения, регистрации, учета и хранения, а также Правил оформления бланков рецептов, в том числе в форме электронных документов" (Зарегистрирован 30.11.2021 № 66124). Доступно по: https://publication.pravo.gov.ru/Document/View/0001202111300115 [Order of the Ministry of Health of the Russian Federation No. 1094n dated 24.11.2021 "On Approval of the Procedure for Prescription of Medicinal Products, Forms of Prescription Forms for Medicinal Products, the Procedure for Registration of Said Forms, Their Accounting and Storage, Forms of Prescription Forms Containing the Prescription of Narcotic Drugs or Psychotropic Substances, the Procedure for Their Manufacture, Distribution, Registration, Accounting and Storage, as well as the Rules for Registration of Prescription Forms, Including in the Form of Electronic Documents" (Registered 30.11.2021 No. 66124). Available at: https://publication.pravo.gov.ru/Document/View/0001202111300115 (in Russian)].

About the Authors

Gennady T. Sukhikh, Academician of the Russian Academy of Sciences, Dr. Med. Sci., Professor, Honored Scientist of Russia, Director, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; Head of the Department of Obstetrics, Gynecology, Perinatology and Reproductology, Institute of Professional Education, Sechenov University (Moscow), +7(495)438-18-00, g_sukhikh@oparina4.ru, https://orcid.org/0000-0002-7712-1260
Vladimir N. Serov, Academician of the Russian Academy of Sciences, Dr. Med. Sci., Professor, President of ROAG, Chief Researcher of the Organizational and Methodological Department of Scientific and Organizational Support, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology,
Ministry of Health of Russia (Moscow), +7(495)531-44-44, v_serov@oparina4.ru
Natalia M. Podzolkova, Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology, RMANPO of the Ministry of Health of Russia; Senior Researcher, Botkin Moscow Multidisciplinary Scientific and Clinical Center (Moscow), podzolkova@gmail.com, https://orcid.org/0000-0001-8991-1369
Igor I. Baranov, Dr. Med. Sci., Professor, Head of the Department of Scientific and Educational Programs, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia (Moscow), +7(495)438-94-92, i_baranov@oparina4.ru
Margarita D. Andreeva, Dr. Med. Sci., Professor, Professor at the Department of Obstetrics, Gynecology and Perinatology No. 2, Kuban State Medical University,
Ministry of Health of Russia (Krasnodar), Chief Freelance Specialist in Obstetrics and Gynecology of the Ministry of Health of the Krasnodar Region, andreeva_md@mail.ru, https://orcid.org/0000-0002-6524-3965
Natalia V. Artymuk, Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology named after Prof. G.A. Ushakova, Kemerovo State Medical University, Ministry of Health of Russia (Kemerovo), +7(3842)73-48-56, +7(960)923-33-55, artymuk@gmail.com
Vitaly F. Bezhenar, Dr. Med. Sci., Professor, Head of the Departments of Obstetrics, Gynecology and Neonatology/Reproductology; Head of the Clinic of Obstetrics and Gynecology, Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia; Chief Freelance Specialist in Obstetrics and Gynecology of the Health Committee of Saint Petersburg (Saint Petersburg), +7(812)338-78-66, bez-vitaly@yandex.ru, https://orcid.org/0000-0002-7807-4929
Natalia V. Dolgushina, Dr. Med. Sci., Professor, Deputy Director – Head of the Department of Scientific Activity Organization, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia (Moscow), +7(495)438-49-77 (ext. 1362), n_dolgushina@oparina4.ru
Svetlana O. Dubrovina, Dr. Med. Sci., Professor, Chief Researcher at the Research Institute of Obstetrics and Pediatrics; Professor at the Department of Obstetrics and Gynecology No. 1, Rostov State Medical University, Ministry of Health of Russia (Rostov-on-Don), https://orcid.org/0000-0003-2424-2672
Rushanya I. Gabidullina, Dr. Med. Sci., Head of the Department of Obstetrics and Gynecology named after Prof. V.S. Gruzdev, Kazan State Medical University,
Ministry of Health of Russia (Kazan), https://orcid.org/0000-0002-5094-7193
Elena V. Enkova, Dr. Med. Sci., Professor at the Department of Obstetrics and Gynecology No. 2, N.N. Burdenko Voronezh State Medical University,
Ministry of Health of Russia (Voronezh), enkova@bk.ru, https://orcid.org/0009-0005-3709-693
Nadezhda Yu. Katkova, Dr. Med. Sci., Head of the Department of Obstetrics and Gynecology, Privolzhsky Research Medical University, Ministry of Health of Russia
(Nizhny Novgorod), katkova_nu@inbox.ru
Igor Yu. Kogan, Corresponding Member of the Russian Academy of Sciences, Dr. Med. Sci., Professor, Director, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology (Saint Petersburg), +7(812)679-55-51, iagmail@ott.ru, https://orcid.org/0000-0002-7351-6900
Vera V. Korennaya, PhD, Associate Professor at the Department of Obstetrics and Gynecology, RMANPO, Ministry of Health of Russia; Chief Freelance Specialist in Gynecology of the Moscow City Health Department; Deputy Chief Physician for Strategic Development, City Clinical Hospital No. 52 (Moscow), drkorennaya@mail.ru, https://orcid.org/009-0000-9612-454X
Irina I. Kukarskaya, Dr. Med. Sci., Professor, Chief Freelance Specialist in Obstetrics and Gynecology of the Tyumen Region Health Department; Head of the Department
of Obstetrics, Gynecology and Perinatology, Institute of Motherhood and Childhood, Tyumen State Medical University; Chief Physician of the Tyumen Regional Perinatal Center; Honored Doctor of Russia (Tyumen), kukarskay@mail.ru
Tatyana A. Makarenko, Dr. Med. Sci., Associate Professor, Head of the Department of Operative Gynecology, Institute of Postgraduate Education, Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia (Krasnoyarsk), +7(904)895-47-99, makarenko7777@yandex.ru, https://orcid.org/0000-0002-2899-8103
Irina V. Molchanova, PhD, Chief Physician, Altai Regional Clinical Perinatal Center; Chief Freelance Specialist in Obstetrics and Gynecology of the Ministry of Health of the Altai Region (Barnaul), +7(903)949-10-64, molcanova2008@yandex.ru
Tatyana A. Nazarenko, Dr. Med. Sci., Professor, Director of the Institute of Reproductive Medicine, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation (Moscow), +7(495)531-44-44, t_nazarenko@oparina4.ru,
https://orcid.org/0009-0006-2251-4100
Anton S. Olenev, Deputy Chief Physician for Obstetric and Gynecological Care, Academician G.M. Savelyeva City Clinical Hospital No. 31; Chief Freelance Specialist in Obstetrics of the Moscow City Health Department (Moscow), OlenevAS@zdrav.mos.ru, https://orcid.org/0000-0001-9632-6731
Irina V. Savelieva, Dr. Med. Sci., Head of the Department of Obstetrics and Gynecology No. 1, Omsk State Medical University, Ministry of Health of Russia; Chief Freelance Specialist in Obstetrics and Gynecology of the Ministry of Health of the Omsk Region (Omsk), akusher_omsk@mail.ru
Yuri A. Semenov, PhD, Chief Physician of the Regional Perinatal Center; Chief Freelance Obstetrician-Gynecologist of the Ministry of Health of the Chelyabinsk Region (Chelyabinsk), u-sirius@mail.ru
Antonina A. Smetnik, PhD, Head of the Department of Gynecological Endocrinology, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation (Moscow), https://orcid.org/ 0000-0002-0627-3902
Natalia V. Spiridonova, Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology, Institute of Postgraduate Education, Samara State Medical University, Ministry of Health of Russia (Samara), https://orcid.org/0000-0003-3928-3784
Natalia I. Tapilskaya, Dr. Med. Sci., Professor, Head of the Department of Reproductology, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology; Professor at the Department of Obstetrics and Gynecology, Saint Petersburg State Pediatric Medical University, Ministry of Health of Russia (Saint Petersburg),
tapnatalia@yandex.ru, https://orcid.org/0000-0001-5309-0087
Nana K. Tetruashvili, Dr. Med. Sci., Head of the 2nd Obstetric Department for Pregnancy Pathology, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia (Moscow), tetrauly@mail.ru
Elena V. Uvarova, Corresponding Member of the Russian Academy of Sciences, Dr. Med. Sci., Professor, Head of the 2nd Gynecological Department (Pediatric and Adolescent Gynecology), Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; Professor at the Department of Obstetrics, Gynecology, Perinatology and Reproductology, Institute of Professional Education, Sechenov University; President of the Interregional Public Organization «Association of Pediatric and Adolescent Gynecologists»; Chief Freelance Pediatric and Adolescent Gynecologist of the Ministry of Health of Russia (Moscow), elena-uvarova@yandex.ru, https://orcid.org/0000-0002-3105-5640
Valentin V. Fadeev, Corresponding Member of the Russian Academy of Sciences, Dr. Med. Sci., Professor, Head of the Department of Endocrinology, Sechenov University (Moscow), walfad@mail.ru, https://orcid.org/0000-0002-3026-6315
Evgeniya V. Shikh, Dr. Med.Sci., Professor, Director of the Institute of Professional Education, Head of the Department of Clinical Pharmacology and Propedeutics of Internal Diseases, Sechenov University (Moscow), +7(499)248-05-53, chih@mail.ru, https://orcid.org/0000-0001-6589-7654
Maria I. Yarmolinskaya, Professor of the Russian Academy of Sciences, Dr. Med. Sci., Professor, Head of the Department of Gynecology and Endocrinology,
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology; Professor at the Department of Obstetrics and Gynecology, I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia; Head of the Center for «Diagnostics and Innovative Methods of Endometriosis Treatment» (Saint Petersburg),
+7(921)916-69-03, m.yarmolinskaya@gmail.com, https://orcid.org/0000-0002-6551-4147
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.